logo
episode-header-image
Aug 2021
18m 34s

Coronapod: COVID boosters amidst global ...

SPRINGER NATURE LIMITED
About this episode

Several wealthy nations have announced plans to give third vaccine doses in a bid to help increase the protection of their most vulnerable citizens - but the science is not clear on whether this strategy will be effective or indeed necessary. Meanwhile with limited vaccine supplies - billions around the world still have no access to vaccines at all. In this episode of Coronapod we discuss the science of boosters, the stark reality of vaccine disparity and what this means for the future of the pandemic.


News: COVID boosters for wealthy nations spark outrage


News feature: COVID vaccine boosters: the most important questions


Coronapod: the inequality at the heart of the pandemic


Coronapod: the biomarker that could change COVID vaccines


Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.



Hosted on Acast. See acast.com/privacy for more information.

Up next
Nov 19
Insulin cream offers needle-free option for diabetes
<h2>00:45 A molecule that delivers insulin through the skin</h2><p>Researchers have developed a skin-permeable polymer that can deliver insulin into the body, which they say could one day offer an alternative to injections for diabetes management. The skin’s structure presents a ... Show More
42m 5s
Nov 14
‘Malicious use is already happening’: machine-learning pioneer on making AI safer
<p>Yoshua Bengio, considered by many to be&nbsp;one of the godfathers of AI,&nbsp;has long&nbsp;been at the forefront of machine-learning research&nbsp;. However, his opinions on the technology have shifted in recent years&nbsp;— he joins us to talk about&nbsp;ways to address the ... Show More
15m 6s
Nov 12
Huge eruption on a distant star confirmed at last
00:45 A coronal mass ejection from a distant starResearchers have detected what they say is the strongest evidence yet of a coronal mass ejection (CME) coming from a star other than our Sun. CMEs are massive bursts of fast-moving plasma that can be detected thanks to the characte ... Show More
33m 51s
Recommended Episodes
Dec 2021
The Evidence: When will the pandemic end?
Everybody hopes that the new super-charged Omicron variant of coronavirus will be less severe, but even if it is, it’s spreading so fast and infecting so many people, health services around the world could still buckle under the strain.Two years into the pandemic, Claudia Hammond ... Show More
50m 9s
Apr 2020
The Race for a Vaccine
<p>Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how t ... Show More
24m 32s
Jun 2021
Covipod #9 : Le vaccin, moins efficace chez certaines personnes
<p>Aujourd'hui, dans Covipod, nous nous penchons sur le cas des personnes que les deux doses de vaccin ne suffisent pas à protéger contre la Covid-19, et sur les mesures à prendre pour s'assurer qu'elles n'attrapent pas la maladie. Nous ferons ensuite un bref état des lieux autou ... Show More
5m 43s
Mar 2021
The State of Vaccinations
<p>The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.</p><p>We look at the ups and downs in the American vacci ... Show More
26m 42s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Aug 2020
How close are we to a vaccine for Covid-19?
Researchers around the world are racing to develop a vaccine against Covid-19, with more than 170 candidate vaccines now in development. Most vaccines take years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine at reco ... Show More
23m 56s